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The identification of molecular networks at the sys-
tem level in mammals is accelerated by next-genera-
tion mammalian genetics without crossing, which
requires both the efficient production of whole-body
biallelic knockout (KO) mice in a single generation
and high-performance phenotype analyses. Here,
we show that the triple targeting of a single gene
using the CRISPR/Cas9 system achieves almost
perfect KO efficiency (96%–100%). In addition, we
developed a respiration-based fully automated non-
invasive sleep phenotyping system, the Snappy
Sleep Stager (SSS), for high-performance (95.3% ac-
curacy) sleep/wake staging. Using the triple-target
CRISPR and SSS in tandem, we reliably obtained
sleep/wake phenotypes, even in double-KO mice.
By using this system to comprehensively analyze all
of the N-methyl-D-aspartate (NMDA) receptor family
members, we found Nr3a as a short-sleeper gene,
which is verifiedbyan independent set of triple-target
CRISPR. These results demonstrate the application
of mammalian reverse genetics without crossing to
organism-level systems biology in sleep research.
INTRODUCTION
The system-level identification of molecular networks in organ-
isms is an important challenge in biology (Kitano, 2002a,
2002b). Classical reverse genetics requires several generations
of animal crosses to produce mutant animals of sufficient quality
and quantity for phenotype analysis. Conventional methods for
producing knockout (KO) mice usually involve targeting-vector662 Cell Reports 14, 662–677, January 26, 2016 ª2016 The Authorsconstruction (2 weeks), the introduction of target mutations
into embryonic stem cells (ESCs) by homologous recombination
(a few weeks), and the injection of the mutant ESCs into wild-
type blastocysts to produce chimera mice (3 weeks). If the
mutant ESCs contribute to the germline of the newborn chimera
mice, their next-generation offspring will possess a heterozy-
gous mutation (3 months). Further crossings of the offspring
(several months to years; at least 3 months per generation) will
produce mice with completely homozygous KO mutations on
an inbred genomic background, which is required for reliable
phenotype analysis. Thus, conventional methods require sub-
stantial amounts of time, space, and effort to knock out even a
single gene (Nagy, 2003). Therefore, identification of molecular
networks comprehensively in organisms will require ‘‘next-gen-
eration’’ genetics, i.e., genetic alterations without crossing. To-
ward this goal, both highly efficient (>90%) mutant production
in a single generation and highly accurate (>90%) phenotype an-
alyses of mutant animals are needed.
The efficient production of biallelic KO mice can be facilitated
by recently developed genome editing techniques, including
ZFNs (zinc-finger nucleases) (Carbery et al., 2010), TALENs (tran-
scription-activator-like effector nucleases) (Sung et al., 2013),
and the CRISPR/Cas nuclease systems (Hsu et al., 2014; Wang
et al., 2013). Unlike the protein-based ZFNs and TALENs, the
CRISPR/Cas system uses RNA-based DNA recognition derived
from a bacterial adaptive immune system (Horvath and Barran-
gou, 2010; Wiedenheft et al., 2012). This method accelerates
the generation of KO animals via the co-injection of RNA encod-
ing the Cas9 protein and target-locus-specific guide RNAs
(gRNAs) into embryos (Fujii et al., 2013; Wang et al., 2013).
Several modifications of the CRISPR/Cas9 system have been
also introduced to improve the efficiency and specificity of tar-
geted mutations in a genome (Fu et al., 2014; Ran et al., 2013;
Zhou et al., 2014). However, two problems remain: (1) first-gener-
ation mice often contain a mosaic of wild-type and KO cells, and
(2) the rate of complete biallelic mutant mice generated is rela-
tively low (usually60%–80% at best). Therefore, the highly effi-
cient (>90%) production of whole-body biallelic KO in a single
generation remains a fundamental challenge for organism-level
systems biology.
The comprehensive identification of molecular circuits at the
organism level also requires accurate (>90%) phenotype anal-
ysis. In neuroscience, sleep/wake behavior is an intriguing
phenotype, because sleep disorders (e.g., insomnia or hyper-
somnia) are sensitive and informative symptoms of almost all
psychological disorders. Sleep/wake states have been charac-
terized in humans by electroencephalography (EEG) and electro-
myography (EMG). For example, during sleep, EEG mostly
displays high-amplitude, low-frequency fluctuations, whereas
during waking, it exhibits low-amplitude, high-frequency fluctu-
ations. On the other hand, EMG displays low-amplitude fluctua-
tions during sleep and high-amplitude fluctuations during
waking. These characteristic EEG/EMG patterns during sleep
and waking are preserved in mammals and can be measured
by electrodes surgically implanted in the brain and muscles.
However, such recording requires special surgical skills, and
the surgery is highly invasive, requiring a long recovery period
(more than 10 days) after implantation before sleep/wake
recording. Furthermore, the EEG/EMG data are often manually
annotated and classified into sleep/wake phenotypes by visual
assessment, which can be time consuming and somewhat
subjective. Therefore, sleep/wake phenotyping has been a
low-throughput method; for comprehensive studies, a scalable,
non-invasive, fully automated sleep/wake recording method is
needed.
In this study, we developed a simple theory to predict the
minimum efficacy of different CRISPR methods for the highly
efficient production of whole-body biallelic KO mice. As
we predicted, triple-target CRISPR elicited almost perfect
(96%–100%) whole-body KO of the Tyrosinase (Tyr) gene,
which is functionally evaluated by animal coat color. This KO ef-
ficiency was confirmed using three independent sets of gRNAs.
The highly efficient production of whole-body KO by the triple-
target CRISPR method also enabled us to obtain clock mutant
phenotypes reliably, not only of Bmal1 single-KO mice but also
ofCry1/Cry2 or Per1/Per2 double-KOmice. For accurate pheno-
type analysis, we developed a respiration-based, non-invasive,
fully automated system, the Snappy Sleep Stager (SSS), which
enabled the high-performance analysis (95.3% accuracy) of
sleep/wake phenotypes. Using the triple-target CRISPR and
SSS methods, we analyzed the N-methyl-D-aspartate (NMDA)
receptor (NMDAR) family comprehensively and found that the
Nr3a KO mouse is a short sleeper (96.7 min/day less than wild-
type). Finally, we developed a freely accessible web-based data-
base that contains the triple-target candidates for 81.2% of the
genes in the mouse genome.
RESULTS
Triple-Target CRISPR Achieves Almost Perfect KO
Efficiency
To obtain a highly efficient method for producing biallelic KO
mice, we first constructed a simple computational model to es-Ctimate the minimum efficacy of different CRISPR methods (Sup-
plemental Experimental Procedures). According to this compu-
tational model, a multiple-target CRISPR strategy, in which
multiple gRNAs target the same gene, is more efficient than
the high-concentration CRISPR strategy, in which a multiple-
fold higher concentration of a single gRNA targets the gene of in-
terest (Figures 1A and 1B; Figures S1A and S1B). This finding is
consistent with a previous report on dual-target CRISPR (Zhou
et al., 2014). Our model further predicted that triple-target
CRISPR would achieve 79%–97% efficiency for the biallelic
KO of a single gene (Figure S1C). Importantly, if it achieves
more than 90% efficiency for the biallelic KO of a single gene,
it can also achievemore than 80%efficiency even for the biallelic
KO of dual genes, which is sufficient for reliable analysis of
behavioral phenotypes.
To test the model’s predictions, we selected Tyr as a target
gene and C57BL/6N as a basal inbred strain, because if this
gene is knocked out biallelically, the black coat color of
C57BL/6N becomes white. We designed three gRNAs for three
target sequences of the Tyr gene (gRNA1, gRNA2, and gRNA3
for targets Tyr-1, Tyr-2, and Tyr-3, respectively; Figures 1C
and S1D). We confirmed that the designed gRNAs had high
cleavage efficiency (7-fold to 40-fold compared to control)
at least in cellulo by using a single strand annealing (SSA) assay
(Figures 1D and S1E), in which the DNA cleavage of a target
sequence by the CRISPR/Cas9 system induced the recombina-
tion of incomplete fragments of firefly Luciferase (Luc), resulting
in an entire Luc gene and enhanced bioluminescence.
We then estimated two parameters of the model, an effective
total gRNA concentration compared to the dissociation constant
of gRNA (S) and a recovery rate of a mutation (a). When injected
into fertilized eggs, the single-target strategy using each of the
three gRNAs alone at 150 ng/ml exhibited only moderate efficacy
(36.0%, 54.2%, and 64.7%, for gRNA1, gRNA2, and gRNA3,
respectively; Figures 1F and S1G). Based on these results, S
and awere estimated to be 5.72 and 0.136, respectively. This al-
lowed us to predict the minimum efficacy of the triple-target
CRISPR method for whole-body biallelic KO mice as 82.6%
(Figure S1F). In fact, the triple-target strategy using the mixture
of Cas9 mRNA (100 ng/ml) and three gRNAs (gRNA1, gRNA2,
and gRNA3, each at 50 ng/ml) achieved almost perfect efficiency
(97.5%; Figures 1E and 1F). We also performed qPCR of the
target region including the CRISPR-target sequence and con-
firmed that five out of six CRISPR-target regions from two Tyr
KO mice were not detectable. These qPCR results matched
with each other among the genomic DNAs extracted frombrains,
scalps, and tails (Figure S1H), which is consistent with the
observed whole-body biallelic KO phenotype (i.e., white coat co-
lor) of the Tyr gene. We noted that observed KO efficacy (97.5%)
is more than the predicted minimum efficiency (82.6%) (Fig-
ure S1F). We speculated that the increased KO efficacy would
be because of irreversible mutations such as deletion between
multiple CRISPR target sites.
To investigate its genomic effect, we performed exome
sequencing; results were that 91.6%–95.6% of target bases
were covered more than ten times (Table S5). As a result, it
demonstrated on-target deletions of genomic stretches with var-
iable lengths (Figure 2) and no off-target mutation. Thus, theell Reports 14, 662–677, January 26, 2016 ª2016 The Authors 663
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Figure 1. A Triple-Target CRISPR Method for Highly Efficient Production of Whole-Body Biallelic KO Mice
(A) Schematic diagram of triple-target and single-target CRISPR methods. Each method uses the same amount of total gRNA.
(B) Computational simulation predicting how efficiently one ormore alleles are cut out when different numbers of gRNAs are used against the same target gene. The
triple-target (red line) and single-target (blue line) methods were compared. The line and shaded area around the line indicate the mean and the SD of 1,000 simu-
lations, respectively. The difference in efficiency between triple-target and single-target strategies becamemore apparent as the number of target alleles increased.
(C) Target sequences of the gRNAs for KO of the Tyrosinase (Tyr) gene. The short colored bars (blue, orange, and green) indicate the 20-base target sequences.
The target sequences were on the sense strand of the genomic DNA (plus sign refers to the gene’s sense strand).
(D) SSA assay for the gRNAs of the Tyr gene. Relative luciferase activities from the SSA vectors (pSSA-Tyr-1 and pSSA-Tyr-2) were measured. The SSA vector
was transfected into 293T cells with empty vector (-), pX330 Cas9 vector without any gRNA, or pX330 Cas9 and Tyr gRNA (Tyr-1, Tyr-2, or Tyr-3). The relative
Luciferase activity for each sample was scaled so that the activity with empty vector (-) was defined as 1. Error bars represent SD (n = 3).
(E) Tyr KO mice created by the triple-target CRISPR method. The coat color showed the biallelically knocked out mice.
(F) Comparison of the single- and triple-target CRISPRmethods. The table shows the gRNA injection condition and resulting phenotypes (Figure S1G). Embryos,
number of injected and transferred embryos; Pups, number of pups born (total); Albino, pups with albino coat color (biallelic knockout); Pigmented, pups with
mosaic or wild-type coat color.
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triple-target CRISPR method could produce biallelic KO mice
with >90% efficiency in a single generation. Furthermore, unde-
tectable expression of TYR protein was confirmed by mass
spectrometry (MS) comparing with another independently pro-
duced triple-target CRISPR KO strain. TYR protein was not
detectable in two Tyr KO mice, whereas it was detected in one
Nr3a KO mouse (Figure S1I). Importantly, since a triple-target
CRISPR method achieves high efficiency (>90%) for the biallelic
KO of a single gene, it has a potential to achieve efficiency higher
than 80% even for the biallelic KO of dual genes, which is suffi-
cient for reliable analysis of behavioral phenotypes.
The SSS Enables Non-invasive, Fully Automated,
High-Performance Sleep/Wake Phenotyping
To identify system-level molecular circuits in organisms, both
the efficient production of KO mice and simple but accurate
phenotyping are necessary. The standard method for pheno-
typing mammals’ sleep/wake states is to record EEG/EMG
data. Each short-period segment of EEG/EMG data, called an
‘‘epoch,’’ is then annotated into one of three sleep/wake states
(‘‘REM [rapid eye movement] sleep,’’ ‘‘NREM [non-REM] sleep,’’
and ‘‘awake’’), determinedby theEEG/EMGpattern (Figure S2A).
Here, to obtain a non-invasive and fully automated method for
simple and accurate sleep/wake phenotype analysis, we devel-
oped the SSS (Figure 3A). For this method, we first focused on
the non-invasive phenotyping of sleep/wake states by recording
the respiration of an animal, since the different states exhibit
unique respiration patterns (Figure S2A).
Among the current methods for non-invasively recording the
respiration of mice (Glaab et al., 2007; Gordon and Ali, 1984),
whole-body plethysmography (WBP) is one of the most popular
and promising. The correlation between respiration patterns and
EEG/EMG-based sleep/wake states was previously analyzed
(Hernandez et al., 2012). However, previous studies mainly
examined short recording periods (less than 1 day) during
different states of consciousness, so the volume of the WBP
chamber could be relatively small. Although a smaller chamber
size increases the sensitivity of the respiration recording, too
small a chamber decreases the animal’s comfort and can affect
sleep/wake behavior. Therefore, no system has been developed
for recording for a week or more, which is critical for accurate
sleep/wake phenotyping. Increasing the size of the chamber re-
quires a compensatory increase in the signal/noise ratio of the
WBP system itself.
To optimize the WBP system, we modeled it as an equivalent
electrical circuit (Figure 3B; Supplemental Experimental Proce-
dures for the detailed equations)—essentially a band-pass filter
for a certain frequency of pressure change. By computer simula-
tion, we optimized the resistance and capacitance in the WBP
system to band-pass the 1- to 10-Hz flow (Figure 3C), which is
the physiological range for mouse respiration frequency. Based
on this analysis, we constructed a high-performance WBP sys-Figure 2. Exome Analysis of Whole-Body Biallelic Tyr KO Mice Produc
Genome alignments of exome sequence reads. The genomic regions targeted by t
part of each panel shows read coverage, and the lower part shows read alignm
Different types of mutations occurring at the target sites are highlighted as follow
inversion mutation (green rectangles); short deletion (red dots); and short insertio
666 Cell Reports 14, 662–677, January 26, 2016 ª2016 The Authorstem (Figure 3A), which exhibited a high signal/noise ratio for
the 1- to 10-Hz flow and allowed us to record detailed, long-
term respiration patterns of mice non-invasively.
For simple and accurate sleep/wake phenotype analyses, fully
automated annotation of the recorded data is also critical. We
previously developed FASTER (an unsupervised fully automated
sleep staging method for mice based on EEG/EMG recordings)
(Sunagawa et al., 2013), which avoids the subjective manual
annotation of EEG/EMG data. We applied the FASTER method
to the recorded respiration data to create a fully automated
annotation pipeline (Figure S2B; Supplemental Experimental
Procedures). Each epoch is annotated as either ‘‘sleep’’ or
‘‘awake’’ fully automatically. Since REM state represented only
5% of the total epochs, which agrees with past documentation
(Chemelli et al., 1999), we focused on a two-state classification
between sleep and awake states as the first-order approxima-
tion in this study. Simultaneous recordings of the respiration
flow and EEG/EMG enabled us to estimate the performance of
the SSS system (Figure 3D), resulting in the high accuracy of
95.3 ± 0.4% (n = 3) for the respiration-based sleep/wake pheno-
typing (Figures 3E and S2C). Importantly, the non-invasiveness
of the recording and fully automated data analysis minimized
the variability and subjectivity of the procedures, thereby making
the sleep/wake phenotyping highly reproducible, as indicated
by the overlapping probability densities of sleep/wake states
among three individuals (Figure 3E). We also note that even
‘‘quiet awake,’’ which was defined in this study as the awake
state accompanied by the lower 33.3% of EMG values, was
annotated accurately (95.3 ± 1.3%; n = 3) by the SSS system
(Figure S2D). Therefore, the SSS provides a non-invasive, fully
automated method for sleep/wake phenotyping.
High-performance in the SSS system enabled us to obtain
various sleep/wake phenotypes based not only on daily sleep
time (or awake time) but also on the transition probabilities be-
tween sleep and awake states (s and w, respectively, in Pws
and Psw; Figure 3F) and on the sleep/wake amplitude, which is
related to the sleep-time variation within the daily sleep cycle
(Figure 3G; Supplemental Experimental Procedures). We note
that Pws and Psw were proposed to represent sleep drive and
wake drive in a previous study (De Valck and Cluydts, 2003)
and that they are informative sleep/wake phenotypes. We also
defined the sleep/wake amplitude as the coefficient of variation
(CV, the SD divided by the mean) of sleep time for each 10-min
bin for 24 hr (Figure 3G).
To evaluate the performance of the SSS system, we recorded
108 individual C57BL/6N male mice (6 weeks old) in the SSS
chamber for a week (Figure 3H; Table S1). To avoid the first-
day effect, the recorded data from the second day to the seventh
day were analyzed by the SSS annotation pipeline. The results
revealed a daily sleep time of 735.7 ± 50.8 min (mean ± SD;
n = 108), which corresponded to a CV of 6.9%. The Pws and
Psw were 0.0379 ± 0.0068 and 0.0363 ± 0.0067, respectively,ed by Triple-Target CRISPR Method
he three gRNAswere shown for wild-type, TyrKO #1, and TyrKO #2. The upper
ents (rectangles). Horizontal lines between rectangles indicate read pairing.
s: inter-exon deletion and inversion (red rectangles); intra-exon deletion and
n (black dots).
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Figure 3. The SSS Enables Non-invasive, Fully Automated, High-Performance Sleep/Wake Phenotyping
(A) The SSS system. Upper left: one mouse is housed in an SSS chamber. The chamber is connected to a water outlet, and food is stored in its ceiling, which
allows 14 days of continuous recording without additional handling of the chamber. Upper right: up to 36 SSS chambers are set in an SSS rack. The rack is
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and the sleep/wake amplitude was 0.4462 ± 0.0530. To evaluate
the SSS system for other inbred strains and in females, we re-
corded C57BL/6J male mice, C57BL/6N female mice, and
C57BL/6J female mice (n = 178, 72, and 173, respectively; Fig-
ure S2E; Table S1). Their tight distributions of sleep time showed
that the SSS provides a simple and high-performance method
for sleep/wake phenotyping.
To further validate the SSS, we recorded various known
sleep/wake phenotypes in mice. First, we tested mice whose
sleep/wake behavior was perturbed pharmacologically. Meth-
amphetamine (MAP), a potent psychostimulant that promotes
wakefulness (Edgar and Seidel, 1997), was injected intraperito-
neally (i.p.) into mice during the day, at zeitgeber time 2 (ZT2;
Figure S3A). The administration of 3 mg/kg MAP significantly
decreased sleep time and Pws (Figures S3B and S3C). These
results indicated that the decreased sleep time was due
to increased stabilization of the awake state rather than by
decreased stabilization of the sleep state.
To test the SSS system for the opposite phenotype (sleep-time
increase), we injected i.p. a sleep-inducing drug, diazepam
(DZP) (Radulovacki et al., 1984), at nighttime, ZT13 (Figure S3D).
Indeed, the administration of 5 mg/kg DZP significantly
increased the sleep time and Pws (Figures S3E and S3F), which
is the exact opposite phenotype observed in MAP injection. To
further confirm observed sleep-phenotype changes, we per-
formed the drug administration experiment under simultaneous
recording of SSS and EEG/EMG (Figures S3H and S3I). The ac-
curacy, sleep sensitivity, sleep specificity, wake sensitivity, and
wake specificity of SSS against EEG/EMG-based sleep staging
were as high as those for wild-type animals (Figures 3D and 3E).
These results clearly show that SSS is highly sensitive to sleep/
wake pattern, even in animals under drug administration.
Furthermore, to test the SSS system’s ability to detect the
sleep/wake phenotypes of genetically modified animals, we re-
corded the behavior of circadianmutants that lose their circadian
rhythm under constant darkness (DD) (Laposky et al., 2005; Shir-
omani et al., 2004; Wisor et al., 2002). Three KO strains, Bmal1
KO (Shimba et al., 2011), Cry1/Cry2 (van der Horst et al.,
1999), and Per1/Per2 double-KOmice (Bae et al., 2001) were re-equipped with continuous air circulation units, which provides fresh air to each
determine the sleep/wake phenotypes of 216 mice per week.
(B) Equivalent electric circuit model of the SSS system. The SSS chamber (red das
pressure sensor (blue dashed box) was modeled with the resister (R2) and capac
(C) Calculation of the conductance over R2, which corresponds to the amplificatio
to maximize the gain of the frequency band of the physiological respiration of mice
6.12 3 105 ml/Pa, and R1 was fixed to 172 Pa , s/ml.
(D) SSS-based sleep/wake staging results compared with conventional EEG/EM
graph shows the sleep time for every 30 min evaluated by SSS. Lower graph sh
30 min during recording.
(E) The performance of SSS. Sleep (red) and awake (blue) states of three indiv
component map in the SSS annotation pipeline. Values represent the mean ± SD
when compared with EEG/EMG-based sleep/wake staging. The overall accurac
(F) Illustration of sleep/wake transitions. Upper left: schematic view of the transi
different values of Pws and Psw. When both Pws and Psw decrease (green circle), b
increase (red diamond), the stability of each state is dramatically decreased (bar
(G) Illustration of sleep/wake amplitude. In the chart, different amplitudes are distin
(H) Distribution of sleep/wake parameters of C57BL/6Nmale mice recorded in the
each distribution, respectively.
See also Table S1 and Supplemental Experimental Procedures.
668 Cell Reports 14, 662–677, January 26, 2016 ª2016 The Authorscorded for a week under LD conditions (light on at ZT0, light off at
ZT12; Figure S3J). All strains exhibited less sleep during the light
phase (an inactive phase of wild-type mice) and more sleep dur-
ing the dark phase (an active phase for wild-type mice; Fig-
ure S3K). Both Pws during the light phase and Psw during the
dark phase are decreased in Bmal1 KO and Cry1/Cry2 double-
KOs (Figures S3L and S3M). Although Per1/Per2 double-KO
mice did not exhibit a significant decrease of sleep/wake ampli-
tude, their daily sleep/wake patterns differed from those of wild-
type mice (Figure S3K). In all strains, the total sleep time was not
significantly different from that of the C57BL/6N mice (Fig-
ure S3M; Table S1). Overall, these results also indicate that the
SSS can sensitively detect various sleep/wake phenotypes,
including the total sleep/wake time, transition probabilities be-
tween sleep and awake states, and sleep/wake amplitude.
Combined Use of a Triple-Target CRISPR
and SSS Enables Sleep/Wake Phenotyping, Even in
Double-KO Mice
To test the feasibility of combining efficient KO mouse produc-
tion with automated sleep/wake phenotyping, we analyzed
sleep/wake phenotypes in different KO mouse lines produced
by the triple-target CRISPR method described earlier. First, we
designed three gRNAs against the Bmal1 gene (Figure S4A).
Sleep/wake phenotyping was performed for animals with the
KO genotype, which was confirmed by qPCR and/or genomic
sequencing (Figures S4D and S4E; Tables S1 and S2). As ex-
pected, the generated Bmal1 KO mice showed a significantly
decreased sleep/wake amplitude under LD conditions com-
pared with wild-type mice, and the Tyr KO mice did not (Figures
4A–4C; Figure S4H). In contrast, the daily sleep times did not
differ between the Tyr KO and Bmal1 KO mice or in comparison
with wild-type mice (Figure 4C). Notably, the Tyr KO mice
had sleep/wake patterns similar to those of the wild-type
mice (Figure 4B), indicating that the triple-target CRISPRmethod
itself had little effect on sleep/wake phenotypes. Next, we gener-
ated double-KO mice for Cry1/Cry2 and Per1/Per2, which are
well-known mouse clock genes. We designed three gRNAs
each for each gene (Figures S4B and S4C), and sleep/wakechamber. Lower panel: we used six SSS racks for recording and thus could
hed box) wasmodeled with a capacitor (C1) and resister (R1) in parallel, and the
itor (C2) in series (Supplemental Experimental Procedures).
n factor of the pressure detected with the sensor and optimization of C2 and R1
(1 to 10 Hz, pink shaded area). Based on the simulation results,C2was fixed to
G-based sleep/wake staging results. Data from three mice were used. Upper
ows the accuracy based on conventional EEG/EMG-based staging, for each
idual mice are shown as probability densities on a two-dimesional principal-
(n = 3) of the sensitivity and specificity of sleep (red) and awake (blue) states
y reached 95.3% ± 0.4% (mean ± SD, green).
tion probabilities between sleep and awake states. Upper right: sleep time at
oth sleep and awake episodes will stabilize. Note that when both Pws and Psw
chart below) without changing the total sleep (or awake) time.
guished by color, and the points represent sleep times at various times of day.
SSS. The pink and sky blue dashed lines show the mean and themean ± SD of
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Figure 4. Combined Use of a Triple-Target
CRISPR and SSS Enables Sleep/Wake Phe-
notyping in Single- and Double-KO Mice
(A) Sleep time (per hour) phenotype for individual
mice in Tyr KO mice and circadian-clock mutants
produced by triple-target CRISPR.
(B) Sleep time (per hour) over 24 hr averaged over
6 days in Tyr KOmice and circadian-clock mutants
produced by triple-target CRISPR. Red lines show
the mean sleep time at each time of day for each
strain. Gray line shows the data for C57BL/6Nmale
mice (n = 108). The shaded area around the line is
the SEM for each time point.
(C) Distributions of sleep/wake parameters of Tyr
KO mice and circadian-clock mutants. Dunnett’s
test compared to C57BL/6N male mice.
(D) Sleep-time (per hour) phenotype of Hcrt KO
mice.
(E) Sleep time (per hour) over 24 hr averaged over
6 days in Hcrt KOmice. Red line, gray line, and the
shaded area are the same as described in (B).
(F) Distributions of sleep/wake parameters of Hcrt
KO mice. Dunnett’s test compared to C57BL/6N
male mice. See also Table S1.phenotyping was performed for animals with the KO genotype
(Figures S4F and S4G; Tables S1 and S2). Both strains showed
similar phenotypes with conventionally generated KO mice (Fig-
ures 4A–4C; Table S1). All three circadian KO strains were also
recorded for a week under DD conditions and confirmed to
exhibit arrhythmic phenotype (Figures S4I and S4J).
To further validate the functionality of our strategy, we de-
signed three gRNAs against the Hcrt gene (Figure S4K) and pro-
duced animals by triple-target CRISPR method. Sleep/wake
phenotyping was performed for animals with KO genotype (Fig-
ure S4L; Tables S1 and S2). Consistent with the conventional
Hcrt KOmice (Chemelli et al., 1999), the mice showed significant
increase in both transition probabilities, Pws and Psw, without any
significant change in total sleep time (Figures 4D–4F and S4M).
Overall, the combinatorial use of triple-target CRISPR and
SSS enables the efficient generation of KO mice and their accu-
rate sleep/wake phenotyping not only in single-KOmice but also
in double-KO mice.
Reverse Genetics without Crossing Reveals Nr3a
Mutant to Be a Short-Sleeper Mouse
Mammalian reverse genetics without crossing can be applied to
the comprehensive analysis of gene functions at the systems
and whole-organism level. To demonstrate proof of concept,Cell Reports 14, 662–677we comprehensively targeted the mem-
bers of the NMDAR family. We focused
on this family because the NMDAR is
implicated in several psychological disor-
ders, including schizophrenia (Belforte
et al., 2010; Moghaddam and Javitt,
2012; Mohn et al., 1999), Alzheimer’s dis-
ease (Snyder et al., 2005), and depression
(Autry et al., 2011; Li et al., 2010), all of
which have associated sleep disorders.
There are seven genes in the NMDAR family: Nr1, Nr2a, Nr2b,
Nr2c, Nr2d, Nr3a, and Nr3b. For triple-target CRISPR, we
designed three gRNAs for each of these genes (Figures S5A–
S5G) and used them to generate KO mice for each one.
Sleep/wake phenotyping was performed for animals with the
KO genotype, which was confirmed by qPCR and/or genomic
sequencing (Figures S5H–S5L; Tables S1 and S2). First, we
confirmed that the lethal phenotype seen in Nr1 and Nr2b bial-
lelic KOmice that was generated by conventional methods (Forr-
est et al., 1994; Li et al., 1994) also occurred in Nr1 and Nr2b KO
mice generated by the triple-target CRISPR method, because
we noted that there were no survivors of Nr1 and Nr2b KO
genotypes (Table S2). KO mice for the other five NMDAR genes,
Nr2a, Nr2c, Nr2d, Nr3a, and Nr3b, survived for at least 6 to
7weeks (Table S2), at which time they were placed in SSS cham-
bers, and their sleep/wake behavior was recorded for at least
1 week under LD conditions. For the phenotype analysis, we
used the 6-day data from the second recording day to avoid
the first-day effect (Figure 5A). The sleep/wake phenotype anal-
ysis was performed fully automatically, and the statistical evalu-
ation used sleep time, Pws, Psw, and sleep/wake amplitude as
parameters (Figures 5B, 5C, and S5M; Table S1).
Among the five KO mice, the Nr3a KO mice showed a sig-
nificant ‘‘short-sleeper’’ phenotype, with a daily sleep time of, January 26, 2016 ª2016 The Authors 669
639.0 ± 17.5 min (n = 8), which is 96.7 min shorter than that of
wild-type mice (p < 0.0001). Nr3a KO mice displayed a lower
Pws than wild-type mice, whereas their Psw was normal (Fig-
ure 5C), indicating that their short-sleeper phenotype was due
to an increase in awake-state stabilization (i.e., longer episode
durations of the awake state) but not a decrease in sleep-state
stabilization. To preclude the possibility of an off-target effect
of CRISPR/Cas9 gene editing, we generated another group of
Nr3a KO mice (n = 12) by an independent CRISPR probe set
(set 2; Figures S6A and S6B; Table S2) and confirmed the
observed short-sleeper phenotype compared with wild-type
mice (p < 0.0001) (Figures 5D–5F and S6C). Furthermore, to
ensure that the short-sleeper phenotype is not due to the modal-
ity of sleep evaluation, we produced another series ofNr3a (set 1)
KO mice (Figure S6D) and used EEG and EMG recordings to
evaluate their sleep. Consistent with the SSS results, EEG re-
cordings showed a significant short-sleeper phenotype in KO
mice (p < 0.05; Figure S6E). For genomic validation, four of the
generated Nr3a KO mice (Figures S5K and S6B) mentioned
earlier were analyzed with exome sequencing (Table S5). In
both set 1 and set 2 animals, the analysis revealed deletions of
genome stretches with variable lengths at the target site (Fig-
ure 6; Figure S7A), with its extent for at least one target site of
up to 100% (see Figure S7B for a magnifiable view). Importantly,
no off-target mutation was identified in this exome sequencing.
These results strongly suggested that the observed short-
sleeper phenotype of Nr3a KO mice cannot be attributed to the
possible off-target effect of CRISPR but rather to the common
genomic defects in the Nr3a gene. Finally, to confirm the
absence of NR3A protein in the KO animals, we have performed
MS analysis in these animals (Figure S6F). Two Tyr KO animals
(Figure S4D) were used as controls for NR3A protein detection,
which showed a clear peak at the position of internal standard
of NR3A protein. By contrast, none of the Nr3a KOmice (Figures
S5K and S6B) had a detectable peak at the position of internal
NR3A protein. These results suggest that Nr3a is knocked
out not only at the genomic level but also at the protein expres-
sion level. Overall, these results demonstrate that the use of
mammalian reverse genetics without crossing, and specifically
combining this efficient KO mouse production with accurate,
automated phenotyping, enables the comprehensive identifica-
tion of shared and diverse functions of gene family members in
organisms.
Developing a Database for the Triple-Target CRISPR
Method
As described earlier, triple-target CRISPR enabled us to effi-
ciently produce biallelic KO mice. However, as we produced
several KO mice using this method, we noticed that manually
designing triple targets for the same gene is still time consuming,
even using existing tools to extract candidate target sequences
for a given genomic sequence (http://cas9.cbi.pku.edu.cn/
index.jsp) (Ma et al., 2013) and to evaluate the off-target risk
for each candidate (http://tools.genome-engineering.org) (Ran
et al., 2013). This manual design procedure takes up to a few
hours for a single gene and, therefore, limits the ability to perform
large-scale screenings. Therefore, we sought to develop an
automatedmethod that performs all of the gRNA selection steps.670 Cell Reports 14, 662–677, January 26, 2016 ª2016 The AuthorsWe scanned the whole mouse genome once, and all of the suit-
able targets are now in an online database (Figure 7A; Supple-
mental Experimental Procedures). This gRNA database provides
at least three target sequences (one set for triple-target CRISPR)
for 81.2%ofmouse genes. In addition, 71.9%of all mouse genes
have more than six target sequences (multiple sets for triple-
target CRISPR), which are also included (Figures 7B and 7C).
To validate the usefulness of the triple-target CRISPR data-
base, we selected two independent sets of triple targets for
the Tyr gene (Tyr-4, Tyr-5, and Tyr-6 for set 2, and Tyr-7, Tyr-8,
and Tyr-9 for set 3; Figure 7D), which were distinct from Tyr-1,
Tyr-2, and Tyr-3 (set 1) used in the previous experiments (Fig-
ure 1C). When injected into fertilized eggs, the triple-target
method using both sets of gRNAs showed almost perfect effi-
cacy (96.6% and 100%, respectively; Figures 7E and 7F), sup-
porting the usefulness of the triple-target CRISPR database.
Therefore, we made this database public (http://crispr.riken.jp/).
DISCUSSION
Triple-Target CRISPR Enables the Efficient Production
of Biallelic KO Mice in a Single Generation
In this study, we sought to achieve the highly efficient (>90%)
production ofwhole-body biallelic KOmice in a single generation.
We used a simple computational model to estimate theminimum
efficacy of different CRISPR methods and discovered that multi-
ple-target CRISPR methods would generate mutant mice with
much higher efficiency than single-target CRISPR. We designed
three different gRNAs against the Tyr gene and confirmed that
the triple-targetCRISPRmethod—usingamixtureof threegRNAs
(Tyr-1, Tyr-2, and Tyr-3)—achieved almost perfect efficacy
(97.5%), whereas the single-targetmethodwith any of the gRNAs
at a 3-fold higher concentration had only moderate efficiency.
Genomic verification revealed no off-target mutation, at least in
exons (Figure 2; Table S5). The total number of gigabase pairs
(or Gbp) read in the exome sequencing including Tyr (set 1),
Nr3a (set 1), and Nr3a (set 2) KOs was 65.6 Gbp. This is more
than 24 times greater than thewhole genomebasepairs ofmouse
(2.7 Gbp). This, therefore, gives us enough coverage to be confi-
dent that off-target effect of the triple-target CRISPR strategy is
not a problem in practice. Importantly, the DNA-cleavage effi-
ciencyof Tyr-3wasmore than 3-fold higher than that of Tyr-2 (Fig-
ure 1D), whereas the whole-body biallelic KO efficiency for Tyr-3
(64.7%)was similar to that for Tyr-2 (54.2%) (Figure 1F), indicating
that a limiting factor in vivo is not DNA cleavage by the CRISPR/
Cas9 system but other factors such as DNA repair, consistent
with the prediction by the computational model. The reproduc-
ibility and robustness of the triple-target method were further
confirmed by additional experiments with two independent sets
of three gRNAs against the Tyr gene (Figures 7E and 7F). We
also confirmed the KO efficiency by genotyping all mice used
for SSS analysis in this study. We genotyped 102 mice produced
by the triple-target CRISPRmethod, including 11 single-KOand2
double-KO strains (Table S2). At least 92.2% (n = 94) of the ani-
mals were confirmed as KO mice by qPCR or sequencing. This
efficacy is confirmed to be higher than the minimum efficacy pre-
dicted by ourmodel. In addition, the triple-target CRISPRmethod
is scalable andcanbeapplied to the identificationof commonand
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Figure 5. Reverse Genetics without Crossing Reveals Nr3a Mutant to Be a Short-Sleeper
(A) Sleep-time (per hour) phenotype for all individual KO mice of five NMDA receptor family members generated by triple-target CRISPR.
(B) Sleep time (per hour) over 24 hr, averaged over six days in KOmice of five NMDA receptor family members. Red lines show themean sleep time at each time of
day for each strain. Gray line shows the data for C57BL/6N male mice (n = 108). The shaded area around the line is the SEM for each time point.
(C) Distributions of sleep/wake parameters of comprehensive KO mice of NMDA receptor family members. Dunnett’s test or Dunnett’s modified Tukey-Kramer
pairwise multiple comparison test compared to C57BL/6N male mice.
(D) Sleep-time (per hour) phenotype of Nr3a KO mice (set 2) generated by triple-target CRISPR.
(E) Sleep time (per hour) over 24 hr, averaged over 6 days in Nr3a KO mice (set 2). Red line, gray line, and the shaded area are the same as described in (B).
(F) Distributions of sleep/wake parameters of Nr3a KO mice (set 2). Dunnett’s test or Dunnett’s modified Tukey-Kramer pairwise multiple comparison test
compared to C57BL/6N male mice.
See also Table S1.diverse functions of a gene family of interest (Figure 5). Further-
more, the triple-targetCRISPRmethod isapplicable to thepheno-
type analysis of double-KO mice (Figures 4A–4C). We alsoCcreated a publicly available CRISPR database that provides tri-
ple-target candidate gRNAs for more than 81.2% of the genes
in the mouse genome (Figure 7A).ell Reports 14, 662–677, January 26, 2016 ª2016 The Authors 671
(legend on next page)
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The SSS Provides a Simple and Accurate Phenotyping
Method for a Complex Behavior
Along with the efficient production of biallelic KO mice, accurate
phenotype analysis is also important tomake full use of mamma-
lian reverse genetics without crossing. In this study, we focused
on the phenotype analysis of sleep/wake states, because sleep
disorders are often associated with psychiatric diseases. The
development of a non-invasive and fully automated method for
sleep/wake phenotyping (the SSS) allowed us to sensitively
detect the sleep-time effects of drugs targeting the CNS,
including a psychostimulant, MAP (dopamine transporter antag-
onist), and a known sleep-inducing drug, DZP (GABAA receptor
agonist) (Figures S3A–S3F). In addition, the SSS enabled us to
accurately and quantitatively analyze other sleep/wake pheno-
types, such as sleep/wake amplitude, which was shown by the
decreased amplitude of clock mutants (Figure 4C), as well as
the transition probabilities from sleep to awake states, and
from awake to sleep states (Figures 3F–3H), which was clearly
shown by the significant increase of Pws and Psw in Hcrt KO
mice (Figure 4F). This ability is useful for dissecting the effects
of CNS drugs on daily sleep time. For example, we found that
the decreased sleep time caused byMAPwas due to an increase
in awake-state stabilization (low Pws) rather than to a decrease in
sleep-state stabilization (Figure S3B). In contrast, the increased
sleep time caused by DZP for 5 hr after the injection was due to a
decrease in awake-state stabilization (high Pws) (Figure S3E),
suggesting that the sleep/wake phenotype induced by DZP is
functionally the opposite of that induced by MAP. Interestingly,
after DZP increased the sleep time (0 to 5 hr after injection), it
conversely decreased the sleep time (5 to 10 hr after injection)
(Figure S3G). This compensatory decrease in sleep time by
DZP was associated with a slight decrease in sleep-state stabi-
lization (highPsw) (Figure S3G; p = 0.0869). These results suggest
that the SSS can sensitively detect and carefully dissect
the common and diverse sleep/wake effects of drugs targeting
the CNS.
The sleep time of two circadian KO animals, Bmal1 KO and
Cry1/Cry2 double-KO mice, recorded in the SSS is not exactly
the same as in past reports (Laposky et al., 2005; Wisor et al.,
2002). This might be partly because of the functional advan-
tages of the SSS system. First, because of its convenience,
the number of recorded mutant mice is larger in this study,
where 34 Bmal1 KO and 27 Cry1/Cry2 KO mice and more
than 100 wild-type mice are recorded. In contrast, nine
Bmal1 KO mice against eight wild-type mice are recorded in
the Laposky et al. (2005) paper, and six Cry1/2 double-KO
mice against eight wild-type mice are recorded in the Wisor
et al. (2002) paper. Second, in both studies, the sleep pheno-
types were evaluated by electrodes implanted in the skull,
which is inevitably invasive. In fact, three out of nine KO mice
were removed from the study after EEG/EMG recording in the
Laposky et al. paper because EEG/EMG signals were deterio-Figure 6. Exome Analysis of Whole-Body Biallelic Nr3a, Set 1, KO Mice
The genomic regions targeted by the three gRNAs were shown for two mice in
coverage, and the lower part shows read alignments (rectangles). Horizontal
occurring at the target sites are highlighted as follows: inter-exon deletion (red re
dots); and short insertion (blue dots).
Crating, which implies some invasiveness inherited in the con-
ventional EEG/EMG recording methods.
Several other approaches have been used in the past to
develop automated non-invasive sleep staging systems. The
video-based sleep stager is non-invasive and can discriminate
between REM and NREM (McShane et al., 2012). However, the
expected drawback is difficulty in parallelization due to the
huge amount of data to be handled. Furthermore, this method
requires a user to set a parameter, which makes it distinct
from the SSS, which requires nomanual optimization. Piezoelec-
tric-based movement detection technology allowed for estima-
tion of the sleep/wake status from the animal motion (Flores
et al., 2007). The simplicity of this system is attractive, although
when performing a high-throughput phenotyping in this system,
we expect its inevitable interference, i.e., the difficulty in assign-
ing the movement information to the recoding animal against the
inevitable noise coming from the neighboring chambers. In
contrast, the SSS only uses single-channel respiration flow infor-
mation per animal, which is a very compact-sized dataset and
the respiration is detected only by the pressure inside the cham-
ber, which is much less prone to be affected from the neigh-
boring chambers. These characteristics make the SSS a much
useful technology.
Regulation of Sleep/Wake States by NMDAR Family
Members
To test the use of our combined method to comprehensively
identify the common and diverse functions of gene family mem-
bers, we separately knocked out all of the NMDAR family mem-
bers. We found that Nr3a KO mice are short-sleeper mutants.
Nr3a expression peaks during early postnatal life and decreases
to lower levels in adulthood (Henson et al., 2010). Unlike the
traditional NMDARs, Nr3a-containing NMDARs have less Ca2+
permeability and are almost completely insensitive toMg2+ block
at hyperpolarized potentials (Sasaki et al., 2002; Tong et al.,
2008). Recently, adult Nr3a KO mice were reported to have
increased pain sensation and enhanced abilities in learning
and memory tasks (Mohamad et al., 2013). These KO mice had
greater long-term potentiation (LTP) in adult hippocampal slices
compared with wild-type slices. Based on these previous find-
ings, we can assume two possible hypotheses to explain the
short-sleeper phenotype in Nr3a KO animals. One is the devel-
opmental circuit influence of Nr3a-containing neurons. Since
Nr3a defect impairs fundamental NMDAR responses that are
deeply related to formation of synaptic networks, the absence
of Nr3a may alter the original sleep regulation network of the
brain. The other is the direct neural activity modulation by
NR3A-containing neurons. Even Nr3a impairment during devel-
opmentmay be complemented by another mechanism; the influ-
ence of Nr3a modulation against neural activity remains until
adulthood. The enhanced LTP can be explained by decreased
blunting of the NMDAR response by Nr3a. Because the NMDARProduced by Triple-Target CRISPR Method
Nr3a (set 1) KO group (Figure S5K). The upper part of each panel shows read
lines between rectangles indicate read pairing. Different types of mutations
ctangles); intra-exon deletion mutation (green rectangles); short deletion (red
ell Reports 14, 662–677, January 26, 2016 ª2016 The Authors 673
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family can be strongly blocked by MK-801, which results in hy-
perlocomotion when administered to mice (Koek et al., 1988),
it is possible that, without Nr3a, the NMDAR response is weak-
ened, and this may result in shorter sleep. To test these hypoth-
eses, conditional perturbation of Nr3a-containing neurons is
necessary in future investigations.
Although the detailed molecular mechanism, in which Nr3a
contributes to the sleep/wake cycle, remains to be elucidated,
the discovery ofNr3a KOmice as a strong short sleeper provides
an interesting entry point for mammalian sleep research. We also
note that, in the fruit fly, forward genetic screenings have shown
that other ion channels play important roles in sleep homeosta-
sis. Mutation in the Shaker gene, which encodes a voltage-
dependent potassium channel, and in the Redeye gene, which
encodes a nicotinic acetylcholine receptor a subunit, both result
in a short-sleeping phenotype (Cirelli et al., 2005; Shi et al., 2014).
Therefore, it will be interesting to investigate the relationship of
themammalian homologs of these channels to NR3A-containing
NMDARs in mammalian sleep.
Toward Organism-Level Systems Biology
In this study, we sought to develop mammalian reverse genetics
without crossing by eliciting the efficient (>90%) production and
accurate (>90%) phenotype analysis of mutant animals in a sin-
gle generation. Mammalian reverse genetics without crossing
(called ‘‘next-generation’’ mammalian reverse genetics) now al-
lows us to test—in whole organisms—hypotheses that are
derived from the past knowledge. For example, a computational
model of slow-wave sleep that provides explanations for the
observed complex dynamics of sleep/wake states, along with
predictions for the important molecular pathways regulating
these states, could be extremely powerful. Previously, it was
difficult to test such predictions, at least without years of labor.
However, the present study demonstrated that the importance
of a predicted molecular pathway can be efficiently tested using
next-generation reverse genetics. Therefore, one of the next
challenges will be to construct a simple computational model
and experimentally validate its predictions using triple-target
CRISPR and/or the SSS. New research fields, including the sys-
tem-level identification and analysis of molecular circuits in
whole organisms, lie ahead.
EXPERIMENTAL PROCEDURES
Animals
C57BL/6NJcl mice were purchased from CLEA Japan, and C57BL/6J mice
were purchased from Oriental Yeast. All mice were given food and water ad
libitum. They were kept in an environment at an ambient temperature
of 21C, with a relative humidity of 50%. The light was controlled under aFigure 7. A Publicly Available Database for the Triple-Target CRISPR M
(A) The pipeline for automatically selecting targets for the triple-target CRISPR m
(B) Distribution of the number of the targets per gene.
(C) Histogram of the number of targets per gene.
(D) Alternative target sequences for the Tyr gene.
(E) Experimental validation of the automatically selected targets for the Tyr gene.
Tyr-8, and Tyr-9 for set 3) were tested. Photographs show the coat color of the
(F) Table shows the injection conditions of the gRNAs and resulting phenotype.
pups (total); Albino, pups with albino coat color (biallelic knockout); Pigmented,
C12-hr/12-hr light/dark cycle. All experimental procedures and housing condi-
tions involving animals and their care were in accordance with the RIKEN Reg-
ulations for Animal Experiments and the Animal Care and the Use Committee
of the Graduate School of Medicine, The University of Tokyo.
One-Cell Embryo Microinjection
C57BL/6N females (4–6 weeks old) were superovulated and mated with
C57BL/6N males. Fertilized eggs were collected from the ampulla of the
oviduct of plugged C57BL/6N females by micro-dissection and kept in
KSOM medium (Merck Millipore) in a 5% CO2 incubator at 37
C. Cas9
mRNA (100 ng/ml) and gRNAs (150 ng/ml in total) were co-injected into the cyto-
plasm of fertilized eggs in M2 medium (Merck Millipore) at room temperature.
Details of the cytoplasmic injection were described previously (Sumiyama
et al., 2010). After microinjection, the injected embryos were cultured for 1 hr
in KSOM medium (Merck Millipore) in a 5% CO2 incubator at 37
C, and
15–30 embryos were then transferred to the oviducts of pseudopregnant
ICR female mice.
Non-invasive Sleep/Wake Phenotype Analysis by SSS Recordings
Mice were placed in the SSS chamber (Figure 3A, upper left panel; Minamide
Rika Shokai), which had an air flow of at least 0.4 l/min. The chamber was con-
nected to the SSS sensor (PMD-8203-2G, Biotex, light brown box on top of the
chamber in Figure 3A), which detected the pressure difference between the
outside and inside of the chamber. The analog signal output from the sensor
was digitized at 250 Hz by an AD converter (ADS-0128aK-64MB, Micro-
science) and stored on a computer by data logging software (Lab-DAQ Pro,
Matsuyama Advance). The analysis of the digitized data was fully automated
as follows: first, the respiration time domain data were converted to frequency
domain data by fast Fourier transformation. The power spectrum was then
subjected to principal-component analysis. The first three principal compo-
nents were used for clustering by probability density clustering (Azzalini and
Torelli, 2007). Finally, the clusters were annotated according to the power
spectrum of each cluster. The details in each step of SSS annotation pipeline
are described in the Supplemental Experimental Procedures. One set of data
recording in the SSS chamber was for 2 weeks. During the experiment, neither
the chamber nor the rack was opened unless the injection was performed i.p.
The light condition of the SSS rack was set to a 12-hr/12-hr light/dark cycle,
and food and water were given ad libitum. Data analysis was conducted
6 days from the second recording date.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, five tables, and a data file showing the source code of the
SSS analysis and can be found with this article online at http://dx.doi.org/10.
1016/j.celrep.2015.12.052.
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